First-in-Human Trial of a Novel Endoluminal Robotic System for En-Bloc Resection of Bladder Tumours - Trial NCT06281080
Access comprehensive clinical trial information for NCT06281080 through Pure Global AI's free database. This phase not specified trial is sponsored by Chinese University of Hong Kong and is currently Not yet recruiting. The study focuses on Bladder Cancer. Target enrollment is 10 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Chinese University of Hong Kong
Timeline & Enrollment
N/A
Jul 01, 2024
Sep 30, 2025
Primary Outcome
Successful en-bloc tumour resection by the robotic system
Summary
This is a prospective, single-arm study to evaluate the feasibility and safety of performing
 transurethral en-bloc resection of bladder tumours using the Zenith robotic system.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06281080
Non-Device Trial